India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

-

Issue dated - 21th Aug 2003

Home > Op-ed

Spurious drugs menace: What can be done?
It is important to understand the problems faced by regulators in catching and punishing the companies and personnel involved in the sale of spurious and counterfeit drugs, writes Dr M Venkateswarlu.

  
INSIDE PHARMA
HAPPENINGS 
CORPORATE 
EDIT 
OP-ED 
BULK DRUG TRENDS 
MARKET PLACE 
PRODUCTS 
CONVERSATION  
RESEARCH 
REACTIONS 
TECHNOLOGY TRENDZ 
HEALTH NEWS 
IN THE NEWS 
MARKET RESEARCH - GLOBAL  


Advanced Search
ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US
 Network Sites

  Express Computer
  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES

 

 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.